United States - English - NLM (National Library of Medicine)

unichem pharmaceuticals (usa), inc. - meloxicam (unii: vg2qf83cgl) (meloxicam - unii:vg2qf83cgl) - meloxicam 7.5 mg - meloxicam tablets are indicated for relief of the signs and symptoms of osteoarthritis [see clinical studies (14.1) ]. meloxicam tablets are indicated for relief of the signs and symptoms of rheumatoid arthritis [see clinical studies (14.1) ]. meloxicam tablets are indicated for relief of the signs and symptoms of pauciarticular or polyarticular course juvenile rheumatoid arthritis in patients who weigh ≥60 kg [see dosage and administration (2.4) and clinical studies (14.2) ]. meloxicam tablets are contraindicated in the following patients: - known hypersensitivity (e.g., anaphylactic reactions and serious skin reactions) to meloxicam or any components of the drug product [see warnings and precautions (5.7, 5.9) ] - history of asthma, urticaria, or other allergic-type reactions after taking aspirin or other nsaids. severe, sometimes fatal, anaphylactic reactions to nsaids have been reported in such patients [see warnings and precautions (5.7, 5.8) ] - in the setting of coronary artery bypass graft (cabg) su

United States - English - NLM (National Library of Medicine)

zydus pharmaceuticals usa inc. - meloxicam (unii: vg2qf83cgl) (meloxicam - unii:vg2qf83cgl) - meloxicam 7.5 mg - meloxicam tablets are indicated for relief of the signs and symptoms of osteoarthritis [see clinical studies  (14.1) ]. meloxicam tablets are indicated for relief of the signs and symptoms of rheumatoid arthritis [see clinical studies  (14.1) ]. meloxicam tablets are indicated for relief of the signs and symptoms of pauciarticular or polyarticular course juvenile rheumatoid arthritis in patients who weigh ≥60 kg [see dosage and administration (2.4) and clinical studies (14.2) ]. meloxicam is contraindicated in the following patients: - known hypersensitivity (e.g., anaphylactic reactions and serious skin reactions) to meloxicam or any components of the drug product [see warnings and precautions (5.7, 5.9) ] - history of asthma, urticaria, or other allergic-type reactions after taking aspirin or other nsaids. severe, sometimes fatal, anaphylactic reactions to nsaids have been reported in such patients [see warnings and precautions (5.7,5.8) ] - in the setting of coronary ar

United States - English - NLM (National Library of Medicine)

belcher pharmaceuticals,llc - meloxicam (unii: vg2qf83cgl) (meloxicam - unii:vg2qf83cgl) - meloxicam 15 mg - meloxicam tablets usp are indicated for relief of the signs and symptoms of osteoarthritis [see clinical studies (14.1)] . meloxicam tablets usp are indicated for relief of the signs and symptoms of rheumatoid arthritis [see clinical studies (14.1)] . meloxicam tablets,usp are indicated for relief of the signs and symptoms of pauciarticular or polyarticular course juvenile rheumatoid arthritis in patients 2 years of age and older [see clinical studies (14.2)] . meloxicam tablets usp are contraindicated in patients with known hypersensitivity (e.g., anaphylactoid reactions and serious skin reactions) to meloxicam. meloxicam tablets usp should not be given to patients who have experienced asthma, urticaria or allergic-type reactions after taking aspirin or other nsaids. severe, rarely fatal, anaphylactic-like reactions to nsaids have been reported in such patients [see warnings and precautions (5.7, 5.13)] . meloxicam tablets usp are contraindicated for the treatment of peri-operative pain in the setting of cor

United States - English - NLM (National Library of Medicine)

bryant ranch prepack - meloxicam (unii: vg2qf83cgl) (meloxicam - unii:vg2qf83cgl) - meloxicam 7.5 mg - meloxicam tablets are indicated for relief of the signs and symptoms of osteoarthritis [see clinical studies (14.1) ]. meloxicam tablets are indicated for relief of the signs and symptoms of rheumatoid arthritis [see clinical studies (14.1) ]. meloxicam tablets are indicated for relief of the signs and symptoms of pauciarticular or polyarticular course juvenile rheumatoid arthritis in patients who weigh ≥60 kg [see dosage and administration (2.4) and clinical studies (14.2) ]. meloxicam tablets are contraindicated in the following patients: - known hypersensitivity (e.g., anaphylactic reactions and serious skin reactions) to meloxicam or any components of the drug product [see warnings and precautions (5.7, 5.9) ] - history of asthma, urticaria, or other allergic-type reactions after taking aspirin or other nsaids. severe, sometimes fatal, anaphylactic reactions to nsaids have been reported in such patients [see warnings and precautions (5.7, 5.8) ] - in the setting of coronary artery bypass graft (cabg) su

Australia - English - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - meloxicam, quantity: 7.5 mg - tablet, uncoated - excipient ingredients: colloidal anhydrous silica; sodium bicarbonate; lactose monohydrate; magnesium stearate; microcrystalline cellulose; croscarmellose sodium - symptomatic treatment of osteoarthritis and rheumatoid arthritis.

Australia - English - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - meloxicam, quantity: 7.5 mg - tablet, uncoated - excipient ingredients: colloidal anhydrous silica; sodium bicarbonate; lactose monohydrate; magnesium stearate; microcrystalline cellulose; croscarmellose sodium - symptomatic treatment of osteoarthritis and rheumatoid arthritis.

Australia - English - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - meloxicam, quantity: 15 mg - capsule, hard - excipient ingredients: lactose monohydrate; maize starch; sodium citrate dihydrate; magnesium stearate; gelatin; titanium dioxide; sunset yellow fcf; brilliant blue fcf; quinoline yellow - meloxicam is indicated for the symptomatic treatment of osteoarthritis and rheumatoid arthritis.

Australia - English - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - meloxicam, quantity: 15 mg - capsule, hard - excipient ingredients: lactose monohydrate; maize starch; sodium citrate dihydrate; magnesium stearate; gelatin; titanium dioxide; sunset yellow fcf; brilliant blue fcf; quinoline yellow - meloxicam is indicated for the symptomatic treatment of osteoarthritis and rheumatoid arthritis.

Australia - English - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - meloxicam, quantity: 15 mg - capsule - excipient ingredients: lactose monohydrate; sunset yellow fcf; quinoline yellow; titanium dioxide; magnesium stearate; gelatin; maize starch; brilliant blue fcf; sodium citrate dihydrate - meloxicam is indicated for the symptomatic treatment of osteoarthritis and rheumatoid arthritis.

Australia - English - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - meloxicam, quantity: 15 mg - capsule - excipient ingredients: sodium citrate dihydrate; maize starch; lactose monohydrate; gelatin; brilliant blue fcf; sunset yellow fcf; quinoline yellow; titanium dioxide; magnesium stearate - meloxicam is indicated for the symptomatic treatment of osteoarthritis and rheumatoid arthritis.